Cargando…
Modified Folfox6 as Adjuvant Chemotherapy in Vietnamese Patients With Colorectal Cancer
Colorectal cancer is the third most common cancer and the second leading cause of death from cancer worldwide. In Vietnam, the disease is the fifth leading cancer (8.9%), with 14 733 new cases in 2018. In recent years, the mFolfox6 regimen has been indicated commonly as the adjuvant chemotherapy aft...
Autores principales: | Nguyen, T. Quang, Bui, T. Oanh, Tran, P. Thao, Tran, V. Thuan, Nguyen, V. Hieu, Chu, Q. Hoan, Bui, T. A. Tuyet, Le, N. Quynh, Le, V. Quang, Dao, V. Tu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640065/ https://www.ncbi.nlm.nih.gov/pubmed/31317770 http://dx.doi.org/10.1177/1073274819864111 |
Ejemplares similares
-
Health-Related Quality of Life Among Vietnamese Breast Cancer Women
por: Tran, Thanh Huong, et al.
Publicado: (2019) -
Role of Baseline Albumin-Bilirubin Grade on Predict Overall Survival Among Sorafenib-Treated Patients With Hepatocellular Carcinoma in Vietnam
por: Nguyen, Thi Thu Huong, et al.
Publicado: (2019) -
Projecting Cancer Incidence for 2025 in the 2 Largest Populated Cities in Vietnam
por: Nguyen, Sang Minh, et al.
Publicado: (2019) -
Epidemiological Characteristics of Advanced Hepatocellular Carcinoma in the Northern Region of Vietnam
por: Le, Van Quang, et al.
Publicado: (2019) -
Cancers in Vietnam—Burden and Control Efforts: A Narrative Scoping
Review
por: Pham, Tung, et al.
Publicado: (2019)